We are live on ! Find out more
FULC icon

Fulcrum Therapeutics
FULC

105 hedge funds and large institutions have $422M invested in Fulcrum Therapeutics in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 23 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,553% more call options, than puts

Call options by funds: $5.16M | Put options by funds: $312K

114% more capital invested

Capital invested by funds: $197M → $422M (+$225M)

65% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 23

19% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 21

5.2% more ownership

Funds ownership: 97.93% → 103.13% (+5.2%)

4% more funds holding

Funds holding: 101 → 105 (+4)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
105
Holders Change
+4
Holders Change %
+3.96%
% of All Funds
1.81%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
38
Reduced
23
Closed
21
Calls
$5.16M
Puts
$312K
Net Calls
+$4.84M
Net Calls Change
+$645K

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$50.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$12M
3
VA
VR Adviser
New York
+$8.59M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$7.52M
5
SI
Sofinnova Investments
California
+$5.71M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.54M
2
N
Nuveen
North Carolina
-$1.74M
3
CSS
Cubist Systematic Strategies
Connecticut
-$1.55M
4
Two Sigma Investments
Two Sigma Investments
New York
-$1.05M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$917K
Name Holding Trade Value Shares
Change 		Change in
Stake
LC
101
Lindbrook Capital
California
$2K +$709 +99 +56%
QCG
102
Quadrant Capital Group
Ohio
$2K +$1.85K +258 New
Daiwa Securities Group
103
Daiwa Securities Group
Japan
$1K – – –
AF
104
Allworth Financial
California
$1K +$465 +65 New
Two Sigma Investments
105
Two Sigma Investments
New York
– -$1.05M -214,763 Closed
Millennium Management
106
Millennium Management
New York
– -$398K -81,197 Closed
Renaissance Technologies
107
Renaissance Technologies
New York
– -$333K -68,000 Closed
TCM
108
Tekla Capital Management
Massachusetts
– -$287K -58,537 Closed
Jane Street
109
Jane Street
New York
– -$186K -37,930 Closed
Qube Research & Technologies (QRT)
110
Qube Research & Technologies (QRT)
United Kingdom
– -$156K -31,813 Closed
Squarepoint
111
Squarepoint
New York
– -$152K -30,936 Closed
Victory Capital Management
112
Victory Capital Management
Texas
– -$147K -30,012 Closed
JF
113
Jump Financial
Illinois
– -$142K -29,000 Closed
XT
114
XTX Topco
Cayman Islands
– -$136K -27,799 Closed
CIC
115
Cornercap Investment Counsel
Georgia
– -$127K -25,941 Closed
EGM
116
Engineers Gate Manager
New York
– -$105K -21,356 Closed
Balyasny Asset Management
117
Balyasny Asset Management
Illinois
– -$77K -15,684 Closed
Simplex Trading
118
Simplex Trading
Illinois
– -$100K -14,005 Closed
AQR Capital Management
119
AQR Capital Management
Connecticut
– -$68K -13,966 Closed
DU
120
Delphia (USA)
Ontario, Canada
– -$58K -11,784 Closed
CC
121
Corton Capital
Ontario, Canada
– -$53K -10,759 Closed
SO
122
STRS Ohio
Ohio
– -$33K -6,800 Closed
PHK
123
Point72 Hong Kong
Hong Kong
– -$22K -4,495 Closed
DA
124
Denali Advisors
California
– -$19K -3,900 Closed
EI
125
Ellevest Inc
New York
– -$29 -4 -9%
1 2 3 4
5

FULC Hedge Fund Activity: Q3 2022 in Review

105 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q3 2022, worth a combined $422M — up 114% from $197M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new FULC positions and 21 closed out — a net gain of 4 holders — while 38 added to existing stakes and 23 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $50.1M. The largest seller was Point72 Asset Management, cutting an estimated $3.54M.

  • 105 institutional investors held Fulcrum Therapeutics (FULC) as of Q3 2022, up from 101 in Q2 2022.
  • Funds reported $422M of Fulcrum Therapeutics stock for Q3 2022, up 114% quarter-over-quarter.
  • 25 funds opened new Fulcrum Therapeutics positions in Q3 2022 and 21 closed out, a net change of +4 holders.
  • The largest Fulcrum Therapeutics buyer in Q3 2022 was RA Capital Management, an estimated $50.1M added.
  • The largest Fulcrum Therapeutics seller in Q3 2022 was Point72 Asset Management, an estimated $3.54M sold.

Based on aggregated 13F filings for Q3 2022.